Kadi Sarva Vishwavidyalaya

About: Kadi Sarva Vishwavidyalaya is a education organization based out in Gandhinagar, Gujarat, India. It is known for research contribution in the topics: Matrix (chemical analysis) & Mass spectrometry. The organization has 131 authors who have published 158 publications receiving 1343 citations.

Mechanochemical synthesis of brexpiprazole cocrystals to improve its pharmaceutical attributes

Abstract: In the present study, cocrystallization of a new piprazole analogue drug, brexpiprazole (BREX), with coformers such as succinic acid and catechol was carried out using ball milling to address the poor solubility and dissolution rate of the molecule. Before initiating cocrystallization, several ball milling process parameters, including milling time, ball size and RPM were optimized to obtain the cocrystals with the highest purity and yield. The cocrystals generated using the optimized ball milling process were characterized using differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), hot stage microscopy, Fourier transform infrared spectroscopy (FTIR) and Raman spectroscopy. Equilibrium solubility and dissolution studies on the cocrystals were performed in 0.05 M acetate buffer, pH 4.3. Nearly 2.5 fold enhancements in the equilibrium solubility and dissolution rate have been observed with the cocrystals compared to plain BREX and its physical mixture with the coformers.

New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics

Abstract: All the heritable alterations in gene expression and chromatin structure due to chemical modifications that do not involve changes in the primary gene nucleotide sequence are referred to as epigenetics. DNA methylation, histone modifications, and non-coding RNAs are distinct types of epigenetic inheritance. Epigenetic patterns have been linked to the developmental stages, environmental exposure, and diet. Therapeutic strategies are now being developed to target human diseases such as cancer with mutations in epigenetic regulatory genes using specific inhibitors. Within the past two decades, seven epigenetic drugs have received regulatory approval and many others show their candidature in clinical trials. The current article represents a review of epigenetic heritance, diseases connected with epigenetic alterations and regulatory approved epigenetic drugs as future medicines.